Contribution: Industrial Research Assistance Program – Contributions to Firms
Orb Therapeutics Inc.
$75,000.00
Development of RNA therapies for therapeutic modulation of expression
EF 2025-26 · 2025-07-15
Résumé
Scalable platform development for programmable genetic medicines, focused on high-throughput screening and functional validation in engineered cell models. The project enables rapid iteration and optimization of therapeutic candidates for severe neurological and metabolic diseases.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Toronto|Toronto, Ontario, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
709922819
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2026-01-27
Agreement Number
1033096
Agreement Start Date
2025-07-15
Agreement Title
Development of RNA therapies for therapeutic modulation of expression
Agreement Title (French)
Développement de thérapies à base d’ARN pour la modulation thérapeutique de l’expression
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Scalable platform development for programmable genetic medicines, focused on high-throughput screening and functional validation in engineered cell models. The project enables rapid iteration and optimization of therapeutic candidates for severe neurological and metabolic diseases.
Description (French)
Développement d’une plateforme évolutive pour les médicaments génétiques programmables, axée sur le criblage à haut débit et la validation fonctionnelle dans des modèles cellulaires modifiés. Le projet permet l’itération rapide et l’optimisation de candidats thérapeutiques pour les maladies neurologiques et métaboliques graves.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
University--Rosedale
Federal Riding (French)
University--Rosedale
Federal Riding Number
35110
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
709922819
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
Orb Therapeutics Inc.
Recipient Postal Code
M5G 1M1
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2025-2026-Q2-1033096
